We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$13.4B
AUM Growth
+$11.7M
Cap. Flow
-$909M
Cap. Flow %
-6.79%
Top 10 Hldgs %
8.68%
Holding
1,051
New
69
Increased
286
Reduced
463
Closed
85

Top Buys

Rank Stock Value
1
HRB icon
H&R Block
HRB
+$34.1M
2
NEWT icon
NewtekOne
NEWT
+$25.9M
3
BVS icon
Bioventus
BVS
+$25.4M
4
TGNA
TEGNA Inc
TGNA
+$24.7M
5
LPX icon
Louisiana-Pacific
LPX
+$24.6M

Sector Composition

Rank Sector Weight
1 Industrials 25.47%
2 Technology 20.75%
3 Financials 14.3%
4 Consumer Discretionary 14.11%
5 Materials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNC icon
501
Tennant Co
TNC
$1.41B
$6.52M 0.05%
80,500
GDXJ icon
502
VanEck Junior Gold Miners ETF
GDXJ
$7.15B
$6.52M 0.05%
155,500
NTUS
503
DELISTED
Natus Medical Inc
NTUS
$6.51M 0.05%
274,459
+94,194
+52% +$2.32M
PROF
504
Profound Medical
PROF
$263M
$6.39M 0.05%
566,498
+48,898
+9% +$611K
INMD icon
505
InMode
INMD
$868M
$6.35M 0.05%
90,000
-40,000
-31% -$3.21M
RCKY icon
506
Rocky Brands
RCKY
$366M
$6.34M 0.05%
+159,318
New +$6.88M
AEHR icon
507
Aehr Test Systems
AEHR
$2.51B
$6.33M 0.05%
261,659
-242,100
-48% -$4.73M
DDS icon
508
Dillards
DDS
$9.41B
$6.32M 0.05%
25,773
-27,647
-52% -$7.27M
EVBG
509
DELISTED
Everbridge, Inc. Common Stock
EVBG
$6.29M 0.05%
93,500
+33,500
+56% +$4.05M
CIT
510
DELISTED
CIT Group Inc.
CIT
$6.28M 0.05%
122,276
-13,354
-10% -$680K
ASC icon
511
Ardmore Shipping
ASC
$703M
$6.26M 0.05%
1,853,307
+135,000
+8% +$521K
ONTF
512
DELISTED
ON24
ONTF
$6.25M 0.05%
360,400
+331,000
+1,126% +$5.9M
CDE icon
513
Coeur Mining
CDE
$15.9B
$6.21M 0.05%
1,232,447
-248,300
-17% -$1.49M
AAOI icon
514
Applied Optoelectronics
AAOI
$7.23B
$6.21M 0.05%
1,208,325
+216,000
+22% +$1.38M
ZUMZ icon
515
Zumiez
ZUMZ
$334M
$6.17M 0.05%
128,651
-435
-0.3% -$19.9K
HWKN icon
516
Hawkins
HWKN
$2.7B
$6.11M 0.05%
154,940
APYX icon
517
Apyx Medical
APYX
$173M
$6.08M 0.05%
474,068
-69,732
-13% -$975K
SITE icon
518
SiteOne Landscape Supply
SITE
$4.15B
$6.06M 0.05%
25,000
COLL icon
519
Collegium Pharmaceutical
COLL
$1.17B
$6.05M 0.05%
323,886
+148,377
+85% +$2.89M
HP icon
520
Helmerich & Payne
HP
$3.37B
$5.95M 0.04%
250,977
+124,638
+99% +$3.55M
WOR icon
521
Worthington Enterprises
WOR
$2.74B
$5.95M 0.04%
176,409
HY icon
522
Hyster-Yale Materials Handling
HY
$600M
$5.92M 0.04%
144,054
-97,391
-40% -$4.25M
IMMR icon
523
Immersion
IMMR
$246M
$5.91M 0.04%
1,034,662
+218,000
+27% +$1.43M
MODV
524
DELISTED
ModivCare
MODV
$5.89M 0.04%
39,744
+1,640
+4% +$254K
MGNI icon
525
Magnite
MGNI
$2.78B
$5.83M 0.04%
333,450

Similar funds

Royce & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Royce & Associates held 1,051 positions worth $13.4B, up 0.09% from $13.4B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Royce & Associates withdrew a net $909M in Q4 2021, closing 85 positions and reducing 463 holdings. Its most notable exit was Meredith Corporation, an estimated $52.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in NewtekOne worth $24.4M.

  • Royce & Associates's largest Q4 2021 buy was NewtekOne: 884,357 shares worth $24.4M.
  • Royce & Associates added most to H&R Block in Q4 2021, an estimated $34.1M increase.
  • Royce & Associates's biggest Q4 2021 reduction was Upland Software, cutting an estimated $53.8M.
  • Royce & Associates fully exited Meredith Corporation in Q4 2021, selling an estimated $52.5M.
  • Royce & Associates's ten largest holdings make up 8.7% of its $13.4B portfolio in Q4 2021.
  • Royce & Associates opened 69 new positions and closed 85 in Q4 2021.
  • Royce & Associates's portfolio value rose 0.09% quarter-over-quarter to $13.4B.

Based on Royce & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.